Ignite Creation Date:
2024-05-06 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04713657
Status:
RECRUITING
Last Update Posted:
2024-06-27
First Post:
2021-01-13
Brief Title:
Beta-blocker Administration for Cardiomyocyte Division
Sponsor:
Weill Medical College of Cornell University
Organization:
Weill Medical College of Cornell University
Study Overview
Official Title:
Mechanistic Clinical Trial of Beta-Blocker Administration For Reactivating Cardiomyocyte Division In Tetralogy of Fallot
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Engaging in study start up activities at new institution
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Heart failure is a common long-term complication in patients with congenital heart disease CHD Medical treatments to promote regeneration of new healthy heart muscle cells have the potential to provide new heart failure treatments for these patients The development of such therapies is limited by the poor understanding of the ways in which heart muscles grow after birth Investigators have learned that humans without heart disease generate new heart muscles cells up to the age of 20 years old and that this is decreased in patients with congenital heart disease like Tetralogy of Fallot Investigators are trying to determine if treatment with a medicine called Propranolol can increase heart muscle cell proliferation and with that normalize heart growth Investigators will examine discarded heart muscle tissue that is obtained during surgery for the presence of new heart muscle cells Propranolol is approved by the Food and Drug Administration FDA to treat a certain kind of benign tumor in infants hemangioma but it is not currently approved by the FDA to increase heart muscle growth
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01HL155597 | NIH | None | None |